Effects of profound platelet inhibition with c7E3 before coronary angioplasty on complications of coronary bypass surgery

Use of a Monoclonal Antibody Directed against the Platelet Glycoprotein IIb/IIIa Receptor in High-Risk Coronary Angioplasty

The EPIC Investigators · New England Journal of Medicine · 1994 · 2.6K citations · Full text

Medicine, Cardiology, Hematology +17

Guidelines for percutaneous transluminal coronary angioplasty. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous Transluminal Coronary Angioplasty).

Thomas J. Ryan, David P. Faxon, R M Gunnar et al. · Circulation · 1988 · 2.1K citations · Full text

Medicine, Cardiology, Internal Medicine +17

Thrombolysis in myocardial infarction (TIMI) trial—Phase I: Hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase

Anupama Rao, Craig M. Pratt, Andrew Berke et al. · Journal of the American College of Cardiology · 1988 · 988 citations

Medicine, Cardiology, Pharmacology +17

Randomised trial of coronary intervention with antibody against platelet IIb/IIIa iritegrin for reduction of clinical restenosis: results at six months

Eric J. Topol, R.M. Califf, Harlan F. Weisman et al. · The Lancet · 1994 · 841 citations

Medicine, Cardiology, Surgery +16

Angiographic and clinical predictors of acute closure after native vessel coronary angioplasty.

Stephen G. Ellis, Gary S. Roubin, Spencer B. King et al. · Circulation · 1988 · 658 citations

Medicine, Cardiology, Surgery +15